NCT04709432 ECMO Treatment of Children in China in the Past 10 Years
| NCT ID | NCT04709432 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Fudan University |
| Condition | Extracorporeal Membrane Oxygenation |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2021-01-11 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2021-01-11 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is a cross-sectional study to summarize the extracorporeal membrane oxygenation （ECMO）treatment in children in China.
Eligibility Criteria
Inclusion Criteria: * age of 1d to 18 years old; * children supported by ECMO in mainland China in the past 10 years Exclusion Criteria: * none
Contact & Investigator
Lu Guoping
STUDY CHAIR
Children's Hospital of Fudan University
Frequently Asked Questions
Who can join the NCT04709432 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, up to 18 Years, studying Extracorporeal Membrane Oxygenation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04709432 currently recruiting?
Yes, NCT04709432 is actively recruiting participants. Contact the research team at jiayundoctor@163.com for enrollment information.
Where is the NCT04709432 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT04709432 clinical trial?
NCT04709432 is sponsored by Children's Hospital of Fudan University. The principal investigator is Lu Guoping at Children's Hospital of Fudan University. The trial plans to enroll 500 participants.